Merck will help rival Johnson & Johnson produce COVID-19 vaccine, possibly doubling supply

Published



The supply of the Johnson & Johnson coronavirus vaccine is set for a big boost, as its fierce competitor, Merck & Co., has agreed to help produce the shots.

Under the deal, to be announced later Tuesday by President Biden, one Merck facility in the United States will manufacture the vaccine, while a second facility will package it.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.